Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Operating activities:      
Net loss $ (6,885) $ (2,891)  
Adjustments to reconcile net loss to net cash used in operating activities      
Depreciation and amortization 454 378  
Loss on impairment of intangible asset 0 180  
Changes in provision for credit losses on accounts receivable 323 20  
Loss (gain) on revaluation of warrant liabilities 727 (1)  
Finance cost associated with warrant issuance 145 (0)  
Loss on impairment of right-of-use asset 89 0  
Stock-based compensation expense 114 250  
Common stock contribution to 401(k) plan 0 (25)  
Unrealized loss (gain) on foreign currency transactions 239 (626)  
Changes in operating assets and liabilities:      
Accounts receivable 2,423 900  
Inventories 168 (379)  
Prepaid expenses and other assets, current and noncurrent (115) 2  
Accounts payable 679 444  
Accrued, lease and other liabilities, current and noncurrent (188) (198)  
Deferred revenues (296) (19)  
Net cash used in operating activities (2,123) (1,965)  
Investing activities:      
Acquisition of property and equipment 0 (10)  
Net cash used in investing activities 0 (10)  
Financing activities:      
Principal payments under notes payable (313) (313)  
Proceeds from issuance of Series B Convertible Preferred Stock and January 2026 Private Placement Warrants, net 5,265 0  
Proceeds from exercise of warrants, net 0 3,842  
Net cash provided by financing activities 4,952 3,529  
Effect of exchange rate changes on cash (5) 7  
Net increase in cash 2,824 1,561  
Cash and restricted cash at beginning of period 1,169 6,493 $ 6,493
Cash and restricted cash at end of period 3,993 8,054 $ 1,169
Supplemental disclosure of cash flow activities      
Cash paid for interest 0 42  
Cash paid for income taxes 3 0  
Supplemental disclosure of non-cash activities      
Deemed dividend in connection with equity financings 376 226  
Fair value of warrants issued in connection with equity financing 2,136 0  
Share issuance for common stock contribution to 401(k) plan $ 0 $ 236